CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 610 enrolled
Drug / intervention
Phenobarbital +1 moredrug
Likely dose
Phenobarbital 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00009620
NCT00009620Phase 3Completed

Randomized Clinical Trial of Antenatal Phenobarbital in the Prevention of Neonatal Intracranial Hemorrhage

NICHD Neonatal Research Network·interventional·Posted Feb 5, 2001·Updated Mar 22, 2019

In Brief

A Phase 3 clinical trial evaluating Phenobarbital and Saline for Infant, Newborn and 4 related conditions. Completed, enrolled 610 participants across 11 sites.

Detailed Summary

This large randomized trial tested whether phenobarbital given to a pregnant woman about to deliver a premature infant would prevent brain injuries in their newborns. Women with 24 to 32 week fetuses who were in preterm labor and were expected to deliver within 24 hrs were randomized to phenobarbital or usual care. They were treated until they deliver or the fetus reaches 33 wks gestation. Babies were followed until discharge and evaluated at 18-22 mos corrected age for neurodevelopmental outcome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 3CompletedFinished
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 5, 2001
Enrollment StartFeb 1, 1993
Primary CompletionFeb 1, 1995
Study CompletionFeb 1, 1997
TodayJul 1, 2026
Enrollment to primary: 2 yearsPosted 25.4 years ago

Interventions

Phenobarbitaldrug

10 mg of phenobarbital per kilogram of body weight intravenously over a period of 20 to 40 minutes (maximal dose, 1000 mg)

Salinedrug

Infusion of normal sal